Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Advancing Nurse-Led Self-Regulation in Multiple Sclerosis Management: Developing an Interactive Web-Based Program through Action Research: Multiple Sclerosis Management.
Mucin degradation by Akkermansia muciniphila promotes Alistipes-dependent tryptophan metabolism and Th17-driven autoimmunity.
Cell-type-specific Mendelian randomization analysis of brain single-nucleus eQTLs and neuromyelitis optica spectrum disorder risk.
Circadian screening of neutrophils identifies therapeutic targets in multiple sclerosis.
Whole-exome sequencing reveals novel and previously reported variants in genes linked to white matter pathology in neurodevelopmental disorders.
Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis.
Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.
Vagus Nerve Hypertrophy in Chronic Inflammatory Demyelinating Polyneuropathy Presenting With Vocal Cord Palsy.
Pontine autosomal dominant microangiopathy with leukoencephalopathy in a Hispanic man without a family history.
Rewiring viral immunity and autoimmunity through neuroimmune circuits.
Discontinuing immunotherapy in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder: Relapse risk and disability outcomes after treatment withdrawal.
Hematopoietic monoamine oxidase A deficiency exacerbates neuroinflammation and demyelination in female but not male mice with experimental autoimmune encephalomyelitis.
Distinct Regulatory DNA Methylation Signatures Across Multiple Sclerosis, Neuromyelitis Optica, and Neurological Post-Acute Sequelae of COVID-19.
The role of the gut microbiome in mediating neuroinflammation in immune-based neurological disorders.
NaHS replenishes hydrogen sulfide levels and rescues myelination defects through NRF2 signaling and iron homeostasis after traumatic brain injury in Swiss albino male mice.
Brain network alterations in autoimmune diseases: Current status and future prospects.
Subacute Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine Exposure Induces Neurobehavioral Deficits and Hippocampal Demyelination in Mice.
Astrocytes in Multiple Sclerosis: Getting to the Core.
Wallerian Degeneration and Nerve Regeneration-A Review of Cellular and Molecular Events.
A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot-Marie-Tooth disease type 1.
Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group.
Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases.
Role of CMTM6 in disease pathogenesis and clinical translation potential (Review).
HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.
Dysregulation of ferroptosis-related plasma biomarkers in treatment-free patients with relapsing-remitting multiple sclerosis in clinical remission: a case-control study.
Pages
« first
‹ previous
…
1033
1034
1035
1036
1037
1038
1039
1040
1041
…
next ›
last »